Jeffrey C. Wang, MD (University of Southern California Spine Center), Raymond J. Hah, MD (Keck School of Medicine at University of Southern California), John C. France, MD (West Virginia University) and Sheeraz A. Qureshi, MD, MBA (Mount Sinai School of Medicine) discuss laminoplasty vs. anterior cervical fusion.

Disclosures:

France, John C.: Nothing to Disclose  

Hah, Raymond J: Consulting: Nuvasive (D).

Qureshi, Sheeraz A: Board of Directors: Minimally Invasive Spine Surgery Group (Nonfinancial); Consulting: Globus (B),  K2M (D), Paradigm Spine (C), RTI (Nonfinancial), Stryker Spine (D); Other: Healthgrades (B); Other Office: AAOS (Nonfinancial, Evaluations Committee member), CSRS (Nonfinancial, Program Committee), CSRS (Nonfinancial, Survey Committee), NASS (Nonfinancial, MIS Committee), NASS (Nonfinancial, Value Committee); Private Investments (including venture capital, start-ups): Avaz Surgical (2%), Vital 5 (2%); Scientific Advisory Board: Onpoint Surgical, Inc. (Nonfinancial), Zimmer (Nonfinancial); Speaking and/or Teaching Arrangements: Globus (Nonfinancial), Medtronic (Nonfinancial), Stryker (Nonfinancial).

Wang, Jeffrey C.: Board of Directors: AOFoundation (C), Cervical Spine Research Society (Travel Expenses), North American Spine Society (Travel Expenses); Fellowship Support: AO Foundation (E, Paid directly to institution/employer); Private Investments: Bone Biologics (less than 1%), electrocore (less than 1%), pearldiver (less than 1%), surgitech (less than 1%); Royalties: Amedica (B), Biomet (F), DePuy Synthes (C), SeaSpine (C).

Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+